title: Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Guaraldi
authors.forename: Chiara
authors.initials: C
authors.lastname: Stentarelli
authors.forename: Gabriella
authors.initials: G
authors.lastname: Orlando
authors.forename: Stefano
authors.initials: S
authors.lastname: Zona
authors.forename: Federica
authors.initials: F
authors.lastname: Carli
authors.forename: Stefano
authors.initials: S
authors.lastname: Ballestri
authors.forename: Amedeo
authors.initials: A
authors.lastname: Lonardo
authors.forename: Nicola
authors.initials: N
authors.lastname: Squillace
authors.forename: Paola
authors.initials: P
authors.lastname: Loria
mesh_terms: D000328:Adult; D001706:Biopsy; D004334:Drug Administration Schedule; D005234:Fatty Liver / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D018894:Reverse Transcriptase Inhibitors